Hospital Admin Articles

Hospital Admin

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

O'Reilly KB – A $2.3 billion settlement with Pfizer Inc. over off–label drug promotion has industry observers wondering whether the record–breaking deal will deter drugmakers from talking up unapproved medication uses with doctors.

Related Articles

Par pharmaceutical receives final approval to market generic ultram er
Par Pharmaceutical, 11/17/09    Relevance Score: 68%

APP Pharmaceuticals Receives Approval for Sumatriptan Succinate Injection, USP
American Pharmaceutical Partners, 10/09/09    Relevance Score: 68%

Teva Receives Final Approval For Generic Prevacid Delayed-Release Capsules
Teva Pharmaceutical Industries, 11/11/09    Relevance Score: 67%

Cephalon Notified of Generic Filing for Armodafinil Tablets
Cephalon, 10/22/09    Relevance Score: 67%

Cell Therapeutics Applies for European Orphan Drug Designation for Pixantrone in Aggressive Non-Hodgkins Lymphoma
Cell Therapeutics, 10/07/09    Relevance Score: 67%

Today in Financial Management...keeping you current

Georgia to receive federal matching funds for electronic health record incentives program
Centers for Medicare & Medicaid Services Press, 12/10/09

Feds to Fund Community I.T. Projects
HealthDataManagement, 12/10/09

Medical Consultation Firm Raises Funds
HealthDataManagement, 12/09/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address